National Institute of Neurological Disorders and Stroke, 23283-23284 [2018-10590]

Download as PDF daltland on DSKBBV9HB2PROD with NOTICES Federal Register / Vol. 83, No. 97 / Friday, May 18, 2018 / Notices Name of Committee: Center for Scientific Review Special Emphasis Panel; Special Emphasis Panel: Brain Injury and Neurovascular Pathologies. Date: June 13, 2018. Time: 1:00 p.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, One Democracy Plaza, 6701 Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Alexei Kondratyev, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5200, MSC 7846, Bethesda, MD 20892, 301–435– 1785, kondratyevad@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Special Emphasis Panel: Brain Injury and Neurovascular Pathologies. Date: June 13, 2018. Time: 1:00 p.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Samuel C. Edwards, Ph.D., Chief, Brain Disorders and Clinical Neuroscience, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5210, MSC 7846, Bethesda, MD 20892, (301) 435–1246, edwardss@ csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Member Conflict: Neural Trauma and Stroke. Date: June 13, 2018. Time: 1:00 p.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Alexei Kondratyev, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5200, MSC 7846, Bethesda, MD 20892, 301–435– 1785, kondratyevad@csr.nih.gov. Name of Committee: Molecular, Cellular and Developmental Neuroscience Integrated Review Group; Molecular Neuropharmacology and Signaling Study Section. Date: June 14–15, 2018. Time: 8:00 a.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Place: Lorien Hotel & Spa, 1600 King Street, Alexandria, VA 22314. Contact Person: Carole L. Jelsema, Ph.D., Chief and Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4176, MSC 7850, Bethesda, MD 20892, (301) 435– 1248, jelsemac@csr.nih.gov. Name of Committee: Oncology 1—Basic Translational Integrated Review Group; Tumor Progression and Metastasis Study Section. Date: June 14–15, 2018. Time: 8:00 a.m. to 5:00 p.m. VerDate Sep<11>2014 16:38 May 17, 2018 Jkt 244001 Agenda: To review and evaluate grant applications. Place: Embassy Suites, DC Convention Center, 900 10th Street NW, Washington, DC 20001. Contact Person: Rolf Jakobi, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 6187, MSC 7806, Bethesda, MD 20892, 301–495– 1718, jakobir@mail.nih.gov. Name of Committee: Population Sciences and Epidemiology Integrated Review Group; Social Sciences and Population Studies B Study Section. Date: June 14–15, 2018. Time: 9:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: Residence Inn, Washington, DC, Downtown, 1199 Vermont Ave. Washington, DC 20005. Contact Person: Kate Fothergill, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3142, Bethesda, MD 20892, 301–435–2309, fothergillke@mail.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Musculoskeletal, Oral, Skin, Rheumatology and Rehab Sciences AREA (R15) Review. Date: June 15, 2018. Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Aftab A. Ansari, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4108, MSC 7814, Bethesda, MD 20892, 301–237– 9931, ansaria@csr.nih.gov. Name of Committee: Bioengineering Sciences & Technologies Integrated Review Group; Biodata Management and Analysis Study Section. Date: June 15, 2018. Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Embassy Suites at the Chevy Chase Pavilion, 4300 Military Road NW, Washington, DC 20015. Contact Person: Wenchi Liang, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3150, MSC 7770, Bethesda, MD 20892, 301–435– 0681, liangw3@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Member Conflict: Neurogenesis and Bioengineering. Date: June 15, 2018. Time: 10:00 a.m. to 1:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Mei Qin, MD, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of PO 00000 Frm 00032 Fmt 4703 Sfmt 4703 23283 Health, 6701 Rockledge Drive, Room 5213, Bethesda, MD 20892, 301–875–2215, qinmei@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Member Conflict: Neuroimmunology, Neuroinflammation, and Brain Tumor. Date: June 15, 2018. Time: 11:00 a.m. to 2:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Center for Scientific Review, 6701 Rockledge Drive, Bethesda, MD 20817 (Telephone Conference Call). Contact Person: Nataliya Gordiyenko, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5202, MSC 7846, Bethesda, MD 20892, 301.435.1265, gordiyenkon@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; PAR15–359: Biomarker Studies for Diagnosing Alzheimer’s Disease and Predicting Progression. Date: June 15, 2018. Time: 11:00 a.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Paula Elyse Schauwecker, Ph.D., Scientific Review Officer, National Institutes of Health, Center for Scientific Review, 6701 Rockledge Drive, Room 5211, Bethesda, MD 20892, 301–760–8207, schauweckerpe@csr.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: May 11, 2018. Sylvia L. Neal, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2018–10589 Filed 5–17–18; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Neurological Disorders and Stroke Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended, notice is hereby given of a meeting of the Interagency Pain Research Coordinating Committee (IPRCC). The meeting will be open to the public. Name of Committee: Interagency Pain Research Coordinating Committee. Type of meeting: Open Meeting. Date: July 9, 2018. E:\FR\FM\18MYN1.SGM 18MYN1 23284 Federal Register / Vol. 83, No. 97 / Friday, May 18, 2018 / Notices Time: 2:00 p.m. to 4:00 p.m. *Eastern Time*. Agenda: The meeting will include discussions of committee business items including an updated Federal Pain Portfolio Analysis and information about the NIH HEAL Initiative. Place: National Institutes of Health, 31 Center Drive, Bethesda, MD 20892 (Telephone Conference Call). Call-In Number: 1–650–479–3208. Public Access Code: 620 284 887. Deadline: Submission of intent to submit written/electronic statement for comments: Wednesday, July 5th, by 5:00 p.m. ET. Contact Person: Linda L. Porter, Ph.D., Director, Office of Pain Policy, Office of the Director, National Institute of Neurological Disorders and Stroke, NIH, 31 Center Drive, Room 8A31, Bethesda, MD 20892, Phone: (301) 451–4460, Email: Linda.Porter@nih.gov. Please Note: Any member of the public interested in submitting written comments to the Committee must notify the Contact Person listed on this notice by 5:00 p.m. ET on Wednesday, July 5, 2018, with their request. Interested individuals and representatives of organizations must submit a written/ electronic copy of the oral statement/ comments including a brief description of the organization represented by 5:00 p.m. ET on Wednesday, July 5, 2018. Statements submitted will be shared with the committee members and become a part of the public record. The meeting will be open to the public for audio access through a telephone call in phone number. Members of the public who participate using the conference call phone number will be able to listen to the meeting as attendees but will not be heard. If you experience any technical problems with the call line, please call Operator Service on (301) 496–4517 for conference call issues and the NIH IT Service Desk at (301) 496–4357. Individuals who participate in person or by using these electronic services and who need special assistance, such as captioning of the call or other reasonable accommodations, should submit a request to the Contact Person listed on this notice at least seven days prior to the meeting. Information about the IPRCC is available on the website: https://iprcc.nih.gov/. Dated: May 11, 2018. Sylvia L. Neal, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2018–10590 Filed 5–17–18; 8:45 am] daltland on DSKBBV9HB2PROD with NOTICES BILLING CODE 4140–01–P VerDate Sep<11>2014 16:38 May 17, 2018 Jkt 244001 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Submission for OMB Review; 30-Day Comment Request Generic Clearance for the Collection of Qualitative Feedback on Agency Service Delivery (National Institute of Nursing Research) National Institutes of Health, Department of Health and Human Services (HHS). ACTION: Notice. AGENCY: In compliance with the requirement of the Paperwork Reduction Act of 1995, the National Institutes of Health (NIH) has submitted to the Office of Management and Budget (OMB) a request for review and approval of the information collection listed below. DATES: Comments regarding this information collection are best assured of having their full effect if received within 30 days of the date of this publication. SUMMARY: Written comments and/or suggestions regarding the item(s) contained in this notice, especially regarding the estimated public burden and associated response time, should be directed to the: Office of Management and Budget, Office of Regulatory Affairs, OIRA_submission@omb.eop.gov or by fax to 202–395–6974, Attention: Desk Officer for NIH. FOR FURTHER INFORMATION CONTACT: To request more information on the proposed project or to obtain a copy of the data collection plans and instruments, contact: Diana Finegold, Division of Science Policy and Public Liaison, NINR, NIH, 31 Center Drive, Building 31, Suite B1B55, Bethesda, MD 20892, or call non-toll-free number (301) 496–0209 or email your request, including your address to: diana.finegold@nih.gov. SUPPLEMENTARY INFORMATION: This proposed information collection was previously published in the Federal Register on March 12, 2018, pages 10734–10736 (83 FR 10734) and allowed 60 days for public comment. No public comments were received. The National Institute of Nursing Research (NINR), National Institutes of Health, may not conduct or sponsor, and the respondent is not required to respond to, an information collection that has been extended, revised, or implemented on or after October 1, 1995, unless it displays a currently valid OMB control number. ADDRESSES: PO 00000 Frm 00033 Fmt 4703 Sfmt 4703 In compliance with Section 3507(a)(1)(D) of the Paperwork Reduction Act of 1995, the National Institutes of Health (NIH) has submitted to the Office of Management and Budget (OMB) a request for review and approval of the information collection listed below. Proposed Collection: Generic Clearance for the Collection of Qualitative Feedback on Agency Service Delivery, 0925–0653, Expiration Date 4/ 30/2018, REINSTATEMENT WITHOUT CHANGE, National Institute of Nursing Research (NINR), National Institutes of Health (NIH). Need and Use of Information Collection: There are no changes being requested for this submission. The information collection activity will continue to garner qualitative customer and stakeholder feedback in an efficient, timely manner, in accordance with the Administration’s commitment to improving service delivery. By qualitative feedback we mean information that provides useful insights on perceptions and opinions but are not statistical surveys that yield quantitative results that can be generalized to the population of study. This feedback will provide insights into customer or stakeholder perceptions, experiences and expectations, provide an early warning of issues with service, or focus attention on areas where communication, training or changes in operations might improve delivery of products or services. These collections will allow for ongoing, collaborative and actionable communications between the Agency and its customers and stakeholders. It will also allow feedback to contribute directly to the improvement of program management. Improving agency programs requires ongoing assessment of service delivery, by which we mean systematic review of the operation of a program compared to a set of explicit or implicit standards, as a means of contributing to the continuous improvement of the program. The Agency will collect, analyze, and interpret information gathered through this generic clearance to identify strengths and weaknesses of current services and make improvements in service delivery based on feedback. The solicitation of feedback will target areas such as: Timeliness, appropriateness, accuracy of information, courtesy, efficiency of service delivery, and resolution of issues with service delivery. Responses will be assessed to plan and inform efforts to improve or maintain the quality of service offered to the public. If this information is not collected, vital feedback from customers and E:\FR\FM\18MYN1.SGM 18MYN1

Agencies

[Federal Register Volume 83, Number 97 (Friday, May 18, 2018)]
[Notices]
[Pages 23283-23284]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-10590]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Neurological Disorders and Stroke

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of a meeting of the Interagency Pain 
Research Coordinating Committee (IPRCC).
    The meeting will be open to the public.

    Name of Committee: Interagency Pain Research Coordinating 
Committee.
    Type of meeting: Open Meeting.
    Date: July 9, 2018.

[[Page 23284]]

    Time: 2:00 p.m. to 4:00 p.m. *Eastern Time*.
    Agenda: The meeting will include discussions of committee 
business items including an updated Federal Pain Portfolio Analysis 
and information about the NIH HEAL Initiative.
    Place: National Institutes of Health, 31 Center Drive, Bethesda, 
MD 20892 (Telephone Conference Call).
    Call-In Number: 1-650-479-3208.
    Public Access Code: 620 284 887.
    Deadline: Submission of intent to submit written/electronic 
statement for comments: Wednesday, July 5th, by 5:00 p.m. ET.
    Contact Person: Linda L. Porter, Ph.D., Director, Office of Pain 
Policy, Office of the Director, National Institute of Neurological 
Disorders and Stroke, NIH, 31 Center Drive, Room 8A31, Bethesda, MD 
20892, Phone: (301) 451-4460, Email: [email protected].
    Please Note:
    Any member of the public interested in submitting written 
comments to the Committee must notify the Contact Person listed on 
this notice by 5:00 p.m. ET on Wednesday, July 5, 2018, with their 
request. Interested individuals and representatives of organizations 
must submit a written/electronic copy of the oral statement/comments 
including a brief description of the organization represented by 
5:00 p.m. ET on Wednesday, July 5, 2018.
    Statements submitted will be shared with the committee members 
and become a part of the public record.
    The meeting will be open to the public for audio access through 
a telephone call in phone number. Members of the public who 
participate using the conference call phone number will be able to 
listen to the meeting as attendees but will not be heard. If you 
experience any technical problems with the call line, please call 
Operator Service on (301) 496-4517 for conference call issues and 
the NIH IT Service Desk at (301) 496-4357.
    Individuals who participate in person or by using these 
electronic services and who need special assistance, such as 
captioning of the call or other reasonable accommodations, should 
submit a request to the Contact Person listed on this notice at 
least seven days prior to the meeting.
    Information about the IPRCC is available on the website: https://iprcc.nih.gov/.

    Dated: May 11, 2018.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2018-10590 Filed 5-17-18; 8:45 am]
 BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.